Related Experiment Video
Updated: May 29, 2025
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
Lipid dysregulation in triple negative breast cancer: Insights from mass spectrometry-based approaches
Xiaoyue Huang1, Ahmed Ali1, Dounia E I Yachioui1
1Metabolomics and Analytics Center, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands.
Abstract:
Triple negative breast cancer (TNBC) has the worst prognosis among breast cancers due to its aggressive nature and the absence of targeted treatments. Development of novel anti-cancer drugs for TNBC faces challenges stemming from its heterogeneity and high potential for metastasis. Metabolomics can be a useful technology in finding novel therapeutic targets and probing the heterogeneity of TNBC. Metabolomics has been enabled by advancements in mass spectrometry (MS)-based platforms that facilitated comprehensive profiling of TNBC metabolism. This review provides an overview of metabolomic changes in TNBC with emphasis on lipid alterations, and describes the key MS analytical techniques, providing the necessary background for examining the role of lipids in TNBC development.
Insights
Triple negative breast cancer (TNBC) is aggressive and lacks targeted treatments. Metabolomics, particularly lipid analysis using mass spectrometry, offers new therapeutic targets for this challenging disease.
Area of Science:
- Oncology
- Metabolomics
- Biochemistry
Background:
- Triple negative breast cancer (TNBC) presents the poorest prognosis due to its aggressive behavior and lack of targeted therapies.
- TNBC's heterogeneity and metastatic potential pose significant challenges for developing effective anti-cancer drugs.
- Metabolomics is emerging as a powerful tool to identify novel therapeutic targets and understand TNBC's complex nature.
Purpose of the Study:
- To review the current understanding of metabolomic alterations in TNBC.
- To highlight the specific role of lipid alterations in TNBC development and progression.
- To provide an overview of mass spectrometry (MS)-based metabolomic techniques applicable to TNBC research.
Main Methods:
- Comprehensive literature review focusing on metabolomics and TNBC.
- Analysis of mass spectrometry (MS) techniques for metabolic profiling.
- Emphasis on lipidomic alterations in TNBC.
Main Results:
- Metabolomic profiling reveals significant alterations in TNBC metabolism.
- Lipid alterations are a key feature of TNBC, influencing its aggressive phenotype.
- Advanced MS platforms enable detailed characterization of TNBC metabolic pathways.
Conclusions:
- Metabolomics, especially lipidomics, is crucial for uncovering TNBC heterogeneity and identifying therapeutic targets.
- Understanding metabolic changes can guide the development of novel anti-cancer drugs for TNBC.
- MS-based metabolomics provides essential insights into the biological mechanisms driving TNBC.
